本研究中第二型糖尿病患白袍高血壓的發生率為 11.8 %，能用來預 測第二型糖尿病患發生白袍效應的因子只有臨床收縮壓值、日夜間血壓 差值與心率變異性總功率。
第二型糖尿病患演進至心血管疾病與神經病變的發生，在病理與生 理上的改變以及治療決策的選擇都是十分複雜的，白袍高血壓或白袍效 應的觀念隨著醫院的文宣，民眾漸漸注意到這樣的現象也意識到求證真 實血壓與適當用藥的重要性。研究中多數個案表示從新陳代謝科門診轉 介至糖尿病諮詢門診，接受相關知識的教育與宣導後除了學會正確服用 藥物，也因為了解必須從運動跟飲食雙管齊下控制糖尿病的觀念，許多
中高齡的個案表示有主動建立自己的運動習慣，因工作無法定期運動的 年輕個案也表示會在飲食上對自己有所限制，這已有別以往國人面對糖 尿病時態度消極的印象，也肯定了糖尿病諮詢室在衛生教育宣導上的功 勞，確實獲得了病患正面的迴響與配合。
我們期望能夠從推行個案自我血壓監測的動作，教育個案以固定的 儀器、固定的肢體、固定的時間或情境以及固定的姿勢測量血壓，建立 對自己居家血壓數值的概念，以利門診時提供醫師作為與臨床血壓值差 別的比較，並初步作為白袍高血壓或白袍效應的參考，倘使對於疑似有 白袍效應或白袍高血壓之個案，醫院能提供動態血壓測量儀的配套測量 做確實鑑別，將對個案血壓狀況的醫療給予更實質的幫助。糖尿病史大 於五年的個案，若能由醫院單位會同研究單位執行心率變異性與心血管 自主神經功能標準測試的評估，也將能提供更有利的證據，佐證藥物治 療的成效。
此外，本研究中許多反向白袍效應組的生理參數，如較大的腰圍 與腰臀比，偏高的三酸甘油酯數值、總膽固醇數值是代謝症候群的危險 因子，再整合上述數值該族群似乎也有肥胖的傾向，若加上較差的動脈 硬化指數，是否也應將反向白袍效應列入與心血管疾病、標的器官傷害 等有關的考量？本研究目前未能有從研究中以足夠的證據來證實反向
白袍效應在心血管相關疾病或代謝相關疾病的致病機轉，但我們臆測反 向白袍效應與這類疾病應具有某種程度的關聯。此外，比較不同疾病類 別有白袍效應或反向白袍效應族群在自主神經功能的表現，也將是一個 等待探究的領域。
參考文獻 中文部份
李文齡（2000）‧第 2 型糖尿病人與嚴格控制高血壓‧臨床醫學，45，
400-403。
林宏達（2003）‧認識糖尿病‧台北：糖尿病協進會。
洪建德（2004）‧台北市糖尿病共同照護網指引‧
http://www.healthcity.net.tw/desease/apply/apply_dia_direction.doc 侯瑞卿（1995）‧內分泌系統疾病‧莊壽洺主編，醫護病理學（524-529
頁）‧台北：華杏。
陳國群（1979）‧161 例糖尿病患之腦血管意外及心肌梗塞‧中華醫誌，
26，260-271。
陳高揚、郭正典、駱惠銘（2000）‧心率變異度：原理與應用‧中華民 國急救加護醫學會雜誌.，11（2），47-57。
蔡世澤（2000）‧臺灣糖尿病照護現況與省思‧臨床醫學，45，316-320。
蔡孟書、吳英黛、詹曉龍、賴金鑫、戴東原（2003）‧糖尿病患者休息 時心率變異性的影響因素‧臺灣醫學會雜誌，7（1），10-18。
英文部份
Akselrod, S., Gordon, D., Ubel, F. A., Shannon, D. C., Berger, A. C., &
Cohen, R. J. (1981). Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat- to beat cardiovascular control. Science, 213(4504), 220-222.
Alberti, K. G. M. M., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO
consultation. Diabetic Medicine, 15, 539-553.
Amado, P., Vasconcelos, N., Santos, I., Almeida, L., Nazare, J., & Carmona, J. (1999). Arterial hypertension difficult to control in the elderly patient.
The Significance of the “white coat effect”. Pevista Portuguesa de cardiologia, 18(10), 897-906.
Andrew, M., Joseph, E. S., Walter, P., Ruth, S. W., Lesley, F., Steven, S., et al., (2004). Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care, 27, 972-977.
Bansal, V., Kalita, V., & Misra, U. K. (2006). Diabetic neuropathy.
Postgraduate Medical Journal, 82, 95-100.
Braune, H. J., & Geisendörfer. U. (1995). Measurement of heart rate variations: influencing factors, normal values and diagnostic impact on diabetic autonomic neuropathy. Diabetes Research and Clinical Practice, 29, 179-187.
Burke, J. P., Williams. K., Gaskill. S. P., Hazuda, H. P., Haffner, S. M., &
Stern, M. P. (1999). Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. Archived Internal Medicine, 159(13), 1450-1456.
Carmona, J., Amado, P., Vasconcelos, N., Almeida, L., Santos, I., Alves, J., et al., (2003). Dose orthostatic hypertension predicts the occurrence of nocturnal arterial hypertension in the elderly patient? Revista Portuguesa de Cardiologia, 22(5), 607-615.
Cerasola, G., Cottone, S., Nardi, E., D’Ignoto, G., Volpe, V., Mulé, G., et al., (1995a). White-coat hypertension and cardiovascular risk. Journal of Cardiovascular Risk, 2, 545-549.
Cerasola, G., Cottone, S., Nardi, E., D’Ignoto, G.,. Volpe, V., Mulé, G., et al., (1995b). White coat hypertension and target organ damage. American Journal of Hypertension, 8 (4), 149A.
between autonomic dysfunction and BP variability in subjects with diabetes mellitus. Journal of Hypertension, 7, 251-255.
Chen, K. T., Chen, C. J., Gregg, E. W., Williamson, D. F., & Narayan, K. M.
V. (1999). High prevalence of impaired fasting glucose and type 2 diabetes mellitus in Penghu Islets, Taiwan: evidence of a rapidly
emerging epidemic? Diabetes Research and Clinical Practice, 44, 59-69.
Chen, H. S., Hwu, C. M., Kuo, B. I., Chiang, S. C., Kwok, C. F., Lee, S. H., et al., (2001). Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabetic Medicine, 18(4), 268-273.
Chou, P., Chen, H. H., & Hsiao, K. J. (1992). Community-based
epidemiological study on diabetes in Pu-Li, Taiwan. Diabetes Care, 15, 81-89.
Chou, P., Liao, M. J., Kuo, H. S., Hsiao, K. J., & Tsai, S. T. (1994). A population survey on the prevalence of diabetes in Kin-Hu, Kinmen.
Diabetes Care, 17, 1055-1058.
Chou, P., Li, C. L., Kuo, H. S., Hsiao, K. J., & Tsai, S. T. (1997).
Comparison of the prevalence of two diabetes surveys between 1987-88 and 1991-92 in Pu-Li, Taiwan. Diabetes Research and Clinical Practice, 38, 61-67.
David, E. S. (2003). Pancreas: Glucose metabolism and diabetes mellitus. In A. P. Sylvia & M. W. Lorraine, Pathophysiology: Clinical Comcepts of Disease Processes (7th. ed., pp.942-935). St. Louis, Missouri: Mosby, Inc.
Davrath, L. R., Goren, Y., Pinhas, I., Toledo, E., & Akselrod, S. (2003).
Early autonomic malfunction in normotensive individuals with a genetic predisposition to essential hypertension. American Journal of
Physiological Heart Circulatory Physiology, 285(4), H1697-H1704.
De Vegt, F., Nijpels, G., Dekker, J. M., Bouter, L. M., Stehouwer, C. D. A.,
& Heine, R. J. (1998). The 1997 American diabetes association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance. Diabetes Care, 21, 1689-1690.
Dolan, E., Stanton, A., Atkins, N., Den Hond, E., Thils, L., McCormack P., et al., (2004). Determinants of white-coat hypertension. Blood Pressure Monitoring, 9(6), 307-309.
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., et al., (1993). The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology, 43(4),
Elisenda, G. A., Alejandro, de La S., Cristina, S., Gianfranco, P., Giuseppe, M., & Antonio, C. (2004). Blood pressure variability and silent cerebral damage in essential hypertension. American Journal of Hypertension, 17, 696-700.
Elvan-Taspinar A., Uiterkamp L. A. M. S., Sikkema J. M., Bots M. L., Koomans H. A., Bruinse H. W., et al., (2003). Journal of Hypertension, 21, 2053-2060.
Federico, A. A., Cecilia, B. C., & Gabriel, W. (2004). The deep-breath test as a diagnostic maneuver for white coat effect in hypertensive patients. The Journal of the American Board of Family Practice, 17, 184-189.
Finlay, A. M., & Sharon, E. S. (2001). What’s this person’s blood pressure?
In D. M. Cynthia (Eds.), Evidence-based Hypertension (pp. 11-32).
Navarra: Graphycems.
George, S. S., Stamatis, P. E., Catherine, K. A., Leonidas, G. R., & Theodore, D. M. (2004). White coat effect in treated versus untreated hypertensivev individuals: A case-control study using ambulatory and home blood pressure monitoring. American Journal of Hypertension, 17, 124-128.
George, L. B., Vivian, F., Richard, E. K., Janet, B. M., Franz, H. M., Robert, A. P., et al., (2004). Metabolic effects of carvedilol vs metoprolol in
patients with type 2 diabetes mellitus and hypertension. Journal of American Medical Association, 292, 2227-2236.
Gerin, W., Ogedegbe, G., Schwartz, J. E., Chaplin, W. F., Goyal, T., Clemow, L., et al., (2006). Assessment of the white-coat effect. Journal of
Hypertensions, 24(1), 67-74.
Gerritsen, J., Dekker, J. M., TenVoorde, B. J., Kostense, P. J., Heine, R. J., Bouter, L. M., et al., (2001). Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes,
hypertension, or a history of cardiovascular disease. Diabetes Care, 24, 1793-1798.
Gibbs, C. R., Murray, S., & Beevers, D. G., (1998). The clinical value of ambulatory blood pressure monitoring. Heart, 79, 115-117.
Grassi, G., Seravalle, G., Colombo, M., Bolla, G., Cattaneo, B. M., Cavagnini, F., et al., (1998). Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation, 97(20).
2037-2042.
Greene, D. A., Lattimer, S. A., & Sima, A. A. (1988). Pathogenesis and prevention of diabetic neuropathy. Diabetes Metabolism Reviews, 4(3),
Guglen, I., Westerhof, B. E., Van Der Sar, G. L., Van Montfrans, G. A.,
Kiemeneij, F., Wesseling, K. H., et al., (2003). Finometer, finger pressure measurements with the possibility to reconstruct brachial pressure. Blood Pressure Monitoring, 8(1), 27-30.
Gustavsen, P. H., Høegholm, A., Bang, L. E., & Kristensen, K. S. (2003).
White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study. Journal of Human Hypertension, 17, 811-817.
György, J., Judit, F., Edina, H., Klára, F., & Judit, N. (1996). Day-night blood pressure variation in normotensive and hypertensive NIDDM patients with asymptomatic autonomic neuropathy. Diabetes Research and Clinical Practice, 34, 107-114.
Habori, M., Mamari, M., & Meeri, A. (2004). Type II diabetes mellitus and impaired glucose tolerance in Yemen: prevalence, associated metabolic changes and risk factors. Diabetes Research and Clinical Practice, 65(3), 275-281.
Haffner, S. M., Lehto, S., Ronnemaa, T., Pyorala, K., & Laakso, M. (1998).
Mortality from coronary heart disease in subjects with type2 diabetes and without prior myocardial in farction. New England Journal of Medicine, 339, 229-234.
Hansen, K. W., Poulsen, P. L., & Mogensen, C. E. (1995). 24-h blood pressure recordings in type I diabetic patients. Journal of Diabetes Complications, 9(4), 237-240.
Hassan, M. O., Al Shafie, O. T., & Johnston, W. J. (1993). Loss of the
nocturnal dip and increased variability of blood pressure in normotensive patients with noninsulin-dependent diabetes mellitus. Clinical Physiology, 13, 519-523.
Hermida, R. C., & Ayala, D. E. (2002). Prognostic value of office and ambulatory blood pressure measurements in pregnancy. Hypertension, 40(3), 298-303.
Hernández del Rey, R., Armario, P., Castellsague, J., Sánchez, P., Cárdenas, G., & Pardell, H. (1995). Cardiovascular risk factors in white coat
hypertension. American Journal of Hypertension, 8(4), 150A.
Hilde, C., & Robert, H. F. (2004). White-coat hypertension: a clinical review.
European Journal of Internal Medicine, 15, 348-357.
Hogan, D., Lurbe, E., Salsbat, M. R., Redon, J., & Batlle, D. (2002).
Circadian changes in blood pressure and their relationships to the development of microalbuminuria in type 1 diabetic patients. Current
Huang, C. J., Kuok, C. H., Kuo, T. B. J., Hsu, Y. W., & Tsai, P. S. (2006).
Pre-operative measurement of heart rate variability predicts hypertension during general anesthesia. Acta Anaesthesiologica Scandinarica, 50, 542-548.
Huggett, R. J., Scott, E. M., Gilbey, S. G., Bannister, J., Mackintosh, A. F., &
Mary, D. A. (2005). Disparity of autonomic control in type 2diabetes mellitius. Diabetologia, 48(1), 172-179.
Imam, I., Oluwole, O. S., & Abbiyesuku, F. (2002). The significance of autonomic symptoms in Nigerian diabetics. African Journal of medicine
& medical science, 31(3), 235-237.
Irene, C., & Gregory, L. Y. H. (2003). White coat hypertension: not so benign after all? Journal of Human Hypertension, 17, 807-809.
James, B. M., Denis, C. M., David, M. N., Deirdre, R. B., & Reubin, A.
(2003). The natural history of progression from normal glucose tolerance to type 2 diabetes in the baltimore longitudinal study of aging. Diabetes, 52 (6), 1475-1484.
Jermendy, G., Ferenczi, J., Hernandez, E., Farkas, K., & Nadas, J. (1996).
Day-night blood pressure variation in normotensive and hypertensive NIDDM patients with asymptomatic automnomic neuropathy. Diabetes
Research and Clinical Practice, 34, 107-114.
Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (2003). The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Journal American Medical Association, 289, 2560-2572.
Jonathan, E. S., & Donald, J. C. (2003). Epidemiology and prevention of type 2 diabetes and the metabolic syndrome. Medical Journal of Australia, 179, 379-383.
Kamoi, K., Miyakoshi, M., Soda, S., Kaneko, S., & Nakagawa, O. (2002).
Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients. Diabetes Care, 25, 2218-2223.
Kario, K., & Pickering, T. G. (2000). White-coat hypertension or white-coat hypertension syndrome: which is accompanied by target organ damage?
Archives of Internal Medicine, 160, 3497-3498.
Karter, Y., Curgunlu, A., Altinisik, S., Erturk, N., Vehid, S., Mihmanli, I., et al., (2003). Target organ damage and changes in arterial compliance in white coat hypertension. Is white coat innocent? Blood Pressure, 12(5-6),
Kato, T., Horio, T., Tomiyamma, M., Kamide, K., Nakamura, S., Yoshihara, F., et al., (in press). Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients. Nephrology, Dialysis, Transplantation.
King, H., Aubert, R. E., & Herman, W. H. (1998). Global burden of diabetes, 1995 –2005. Prevalence, numerical estimates, and projections. Diabetes Care, 21, 1414-1431.
King, H., & Rewers, M. (1993). Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Diabetes Reporting Group. Diabetes Care, 16(1), 157-77.
Kondo, K., Matsubara, T., Nakamura, J., & Hotta, N. (2001). Characteristic patterns of circadian variation in plasma catecholamine levels, blood pressure and heart rate variability in type 2 diabetic patients. Diabetics Medicine, 19(5), 359-365.
Laffer, C. L., & Elijovich, F. (1994). Predictors of the pressor response to the clinic visit in essential hypertensives with and without diabetes mellitus.
Clinical Autonomic Research, 4, 323-329.
L. Aldo, F., Lucio, G., Fabio, F., Giuliano, De. L., Rosaria, C., Stefania, V., et al., (in press). Blood pressure at rest, during 24h monitoring and in
response to sympathetic stimulation in hypertensive patients with metabolic syndrome. International Journal of Cardiology.
Lawrence, I. G., Weston, P. J., Bennett, M. A., McNally, P. G., Burden, A. C.,
& Thurston, H. (1997). Is impaired baroreflex sensitivity a
predictor or cause of sudden death in insulin-dependent diabetes mellitus?
Diabetic Medicine, 14(1), 82-85.
Lin, K. P., Kwan, S. Y., Chen, S. Y., Chen, S. S., Yeung, K. B., Chia, L. G., et al., (1993). General neuropathy in Taiwan: an etiologic survey.
Neuroepidemiology, 12(5), 257-261.
Lin, R. S., & Lee, W. C. (1992). Trends in mortality from diabetes mellitus in Taiwan, 1960-1988. Diabetologia, 35(10), 973-979.
Lin, J. D., Shieh, W. B., Huang, M. J., & Huang, H. S. (1993). Diabetes mellitus and hypertension based on the family history and 2-h
postprandial blood sugar in the Ann-Lo district (Northern Taiwan).
Diabetes Research and Clinical Practice, 20(1), 75-85.
Linda, C. D. (2003). Cardiovascular system disorder: Anotomy of the Cardiovascular System. In A. P. Sylvia & M. W. Lorraine,
Pathophysiology: Clinical Comcepts of Disease Processes (7th. ed., pp.
Lindbaek, M., Sandvik, E., Liodden, K., Mjell, J., & Ravnsborg-Gjertsen, K., (2003). Predictors for the white coat effect in general practice patients with suspected and treated hypertension. The British journal of general practice: the journal of the Royal College of general practitioners, 53(495), 790-793.
Lindsay, R. S., Stewart, M. J., Nairn, I. M., Baird, J. D., & Padfield, P. L.
(1995). Reduced diurnal variation of blood pressure in
non-insulin-dependent diabetic patients with microalbuminuria. Journal of Human Hypertension, 9 (4), 223-227.
Liniger, C., Favre, L., & Assal, J. (1991). Twenty -four hour blood pressure and heart rate profiles of diabetic patients with abnormal cardiovascular reflexes. Diabetic Medicine, 8, 420-427.
Macleod, A., & Sönksen, P. (1996). Diabetic Neuropathy. In K. M. Shaw (Ed.), Diabetic Complications (pp. 123-47). NY: Wiley.
Mallion, J. M., Bauguet, J. P., Siche, J. P., Tremel, F., & De Gaudemaris, R.
(1999). Clinical value of ambulatory blood pressure monitoring. Journal of Hypertension, 17(5), 585-595.
Mancia, G., Bertinieri, G., Grassi, G., Parati, G., Pomidossi, G., Ferrari, A., et al., (1983). Effect of blood-pressure measurement by the doctor on
patient’s blood pressure and heart rate. Lancet, 2(8352), 695-698.
Mardarowicz, G., Lopatynski, J., & Nicer, T. (2003). Metabolic syndrome.
Annals of University Mariae Cruie Sklodowska, 58(1), 426-31.
Massin, M. & von Bernuth, G. (1998). Clinical and haemodynamic correlates of heart rate variability in children with congenital heart disease. European Journal of Pediatrics, 157(12), 967-971.
Matsuoka, T., Himei, H., & Kawanishi, Y. (1995). A newly developed
method to assess autonomic nerve function in diabetic patients. Diabetic neuropathy: new concepts and insights, Nov(3-5), 343-346.
May, O., & Arildsen, H. (2000). Assessing cardiovascular autonomic neuropathy in diabetes mellitus how many tests to use? Journal of Diabetes and Its Complications, 14, 7-12.
Medet, J., Yukio, O., Hiroshi, K., Satoshi, S., Yoichi, I., Hiromi, M., et al., (2005). White coat hypertension in centenarians. American Journal of Hypertension, 18, 1040-1045.
Migdalis, I. N., Zachariadis, D., Hatzigakis, S. M., Kourti, A., & Kalantzis, L. (1996). Ambulatory blood pressure measurement in type-II diabetic patients with autonomic neuropathy. Journal of Medical, 27(5-6),
Momin, M. G., Janine, R., Robert, L. H., Peter, H. B., Dana, D., William, C.
K., et al., (2000). The 1997 American Diabetes Association and 1999 World Health Organization a Criteria for Hyperglycemia in the Diagnosis and Prediction of Diabetes. Diabetes Care, 23(8), 1108-1112.
Muldoon, M. F., Nazzaro, P., Sutton-Tyrrell, K., & Manuck, S. B. (2000).
White coat hypertension and carotid artery atherosclerosis. Archives of Internal Medicine, 160, 1507-1512.
Myers, M. G. (2001). Ambulatory blood pressure monitoring in clinical practice. Canadian Journal of Cardiology, 17(5), 581-586.
Neumann, S. A., Jennings, J. R., Muldoon, M. F., & Manuck, S. B. (2005).
White-coat hypertension and autonomic nervous system dysregulation.
American Journal of Hypertensions, 18(5 Pt 1), 584-588.
Nielsen, F. S., Gaede, P., Vedel, P., Pedersen, O., & Parving, H. H. (1997).
White coat hypertension in NIDDM patients with and without incipient and overt diabetic nephropathy. Diabetes Care, 20(5), 859-863.
Nielsen, F. S., Hansen, H. P., Jacobsen, P., Rossing, P., Smidt, U. M., Christensent, N. J., et al., (1999). Increased sympathetic activity during sleep and nocturnal hypertension in type 2 diabetic patients with diabetic neuropathy. Diabetic Medicine, 16, 555-562.
O’Brien, E., Atkins, N., & Staessen, J. (1995). Sate of the market.
Hypertension, 26, 835-842.
O’Brien, E., Mee, F., Atkins, N., & O’Mally, K. (1991). Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society Protocol. Journal of Hypertension, 9, 573-574.
O’Brien, E. (2003). Ambulatory blood pressure monitoring in the management of hypertension. Heart, 89, 571-576.
Owens, P., Atkins, N., & O’Brien, E. (1999). Diagnosis of white coat
hypertension by ambulatory blood pressure monitoring. Hypertension, 34, 267-272.
Parati, G., Omboni, S., Staessen, J., Thijs, L., Fagard, R., Ulian, L., et al., (1998). Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the “white-coat”effect. Syst-Eur investigators. Journal of Hypertentions, 16(1), 23-29.
Pickering, T. G., James, G. D., Boddie, C., Harshfield, G. A., Blank, S., &
Laragh, J. H. (1988). How common is white-coat hypertension? The Journal of the American Medical Association, 259, 225-228.
Pickering, T. G., Andrew, C., Jean, M. M., Giuseppe, M., & Paolo, V. (1999).
333-341.
Reardon, M., & Malik, M. (1996). Changes in heart rate variability with age.
Pacing in clinical electrophysiology, 19(11 pt 2), 1093-1099.
Reaven, P. (2004). Metabolic syndrome. Journal of Insurance Medicine, 36(2), 132-142.
Roberto, S., Giuseppe, T., Arturo, L., Stefano, C., Giancarlo, C., Riccardo, S., et al., (2001). Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension. data from the general population (Pressione Arteriose Monitorate E Loro Associazion
Roberto, S., Giuseppe, T., Arturo, L., Stefano, C., Giancarlo, C., Riccardo, S., et al., (2001). Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension. data from the general population (Pressione Arteriose Monitorate E Loro Associazion